GENEGINI LIMITED
Significant control: Philip Day (50–75%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Genegini Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Genegini Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
GENEGINI LIMITED is an active private limited company (company number 13231160) incorporated on 27 February 2021, registered in Manchester. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 28 February 2025, showing net assets of £180k, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets were unchanged on the prior period.
By net assets it sits in the top quarter of 138 comparable companies in Manchester (median £436, upper quartile £124k).
Ownership and control
- Dr Philip Day
- owns 50–75% of shares
- holds 50–75% of voting rights
- The University Of Manchester
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 27 February 20215 yrs ago
- Next accounts due
- 28 November 2026in 32 days
- Confirmation statement due
- 13 March 2027in 137 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 28 February 2025 | £180k | — | — | £0 | — | — | 0 |
| 28 February 2024 | £180k | — | — | £0 | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets above zeroNet assets £179,645 at 28 February 2025
- Incorporated five or more years agoIncorporated 27 February 2021
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 137 days
- Next accounts duein 32 days
- Accounts period endNet assets £180k · micro accounts
- Accounts period endNet assets £180k · micro accounts
- Incorporated
Similar companies in Manchester
- RAVAN BIO LIMITEDSale · inc. Mar 2021
- RESEARCH MASTERS LTDOldham · inc. Mar 2021
- DRUG DISCOVERY CONSULTANTS LIMITEDStockport · inc. Feb 2021
- ORGANOID SOLUTIONS LTDManchester · inc. Mar 2021
- INPEPCIDE LIMITEDManchester · inc. Mar 2021
- INNOVATE ANTI-INFECTIVES LTDManchester · inc. Jan 2021
All companies incorporated on 27 February 2021 · in Feb 2021.
Reminders for GENEGINI LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.